TY - JOUR AU - Ferdinand, Keith C. AU - Mahata, Indrajeet PY - 2017 TI - Cardiovascular outcome studies with glucagon-like peptide 1 receptor agonists—what will REWIND add? JF - Annals of Translational Medicine; Vol 5, No 23 (December 07, 2017): Annals of Translational Medicine Y2 - 2017 KW - N2 - Type 2 diabetes mellitus (T2DM) is a complex metabolic disease with hyperglycemia and an associated high risk of cardiovascular disease (CVD), including macrovascular and microvascular complications. In addition, CVD mortality rates appear two fold higher among individuals with diabetes mellitus (DM) when compared to individuals without DM (1,2). UR - https://atm.amegroups.org/article/view/17310